74.56
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Alcon Inc Aktie (ALC) Neueste Nachrichten
Sight Sciences wins $34M patent ruling against Alcon - MSN
How The LENSAR (LNSR) Story Is Shifting After The Failed Alcon Deal And Target Reset - Yahoo Finance
Alcon Sets April 30, 2026 AGM, Proposes New Director and CHF 0.28 Dividend - The Globe and Mail
AB SUSTAINABLE INTERNATIONAL THEMATIC FUND INC's Alcon Inc(XSWX:ALC) Holding History - GuruFocus
Alcon Inc stock: Steady eye care leader amid market pressures? - AD HOC NEWS
Alcon Inc. (ALC) Stock Price, News, Quote & History - Yahoo Finance
Systane eye drops: Are Alcon’s German bestsellers worth it in the US? - AD HOC NEWS
Nanoscope Therapeutics Names Former Alcon Exec as Its New COO - National Today
Alcon Inc. (ALC) stock price, news, quote and history - Yahoo Finance Singapore
Alcon Publishes Agenda for 2026 Annual General Meeting - Yahoo Finance
Nanoscope brings in Alcon veteran as COO ahead of launch phase - The Pharma Letter
ALC Stock Price, Quote & Chart | ALCON INC (NYSE:ALC) - ChartMill
Alcon Inc. announces Annual dividend, payable on May 07, 2026 - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Alcon (ALC) and HCA Healthcare (HCA) - The Globe and Mail
Systane Eye Drops: Alcon's Leading Dry Eye Relief Product Driving Steady Growth in North American Op - AD HOC NEWS
List of 19 Acquisitions by Alcon (Apr 2026) - tracxn.com
Lensar outlines 46%–49% gross margin forecast for 2026 as it restarts growth after Alcon deal termination - MSN
Alcon Inc Stock Faces Patent Setback and Merger Termination: Key Implications for NYSE:ALC Investors - AD HOC NEWS
Volume Report: Is Alcon Inc benefiting from innovation trendsDay Trade & Verified High Yield Trade Plans - baoquankhu1.vn
Street Watch: Should I hold or sell Alcon Inc now2026 PreEarnings & Weekly Top Stock Performers List - baoquankhu1.vn
Sight Sciences wins $34M in Alcon patent case, ongoing royalty - Investing.com Australia
Alcon (ALC) Faces $34 Million Verdict in Patent Case - GuruFocus
Alcon Fails to Undo $34 Million Patent Loss, Must Pay Royalties - Bloomberg Law News
Sight Sciences Wins $34 Million Patent Infringement Case Against Alcon, Secures Ongoing Royalties Through 2028 - minichart.com.sg
Sight Sciences Wins Infringement Lawsuit Against Alcon - National Today
Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent - The Manila Times
Sight Sciences (NASDAQ: SGHT) awarded $34M plus 10% Hydrus royalties - Stock Titan
Alcon Inc Stock: A Leader in Eye Care with Strong Growth Potential for North American Investors - ad-hoc-news.de
Aug Drivers: Will Alcon Inc stock go up in YEARQuarterly Portfolio Report & Long-Term Safe Investment Ideas - baoquankhu1.vn
Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN
Alcon Inc Stock: Global Leader in Eye Care with Strong Growth Potential for North American Investors - AD HOC NEWS
Alcon announces $81 million expansion in Cabell County, 75 new jobs expected - WOWK 13 News
Alcon Inc Stock: Global Leader in Eye Care Innovation and Steady Growth Potential for Investors - AD HOC NEWS
Alcon Inc. Stock: A Leader in Eye Care Innovation Driving Steady Growth for North American Investors - AD HOC NEWS
Alcon expansion to create more West Virginia jobs - DC News Now
Alcon in Lesage to start making new vision product - WOWK 13 News
Systane Eye Drops: Alcon's Leading Solution for Dry Eye Relief in North America - AD HOC NEWS
Analyst Upgrade: Is Alcon Inc benefiting from innovation trendsPortfolio Update Report & Expert Verified Movement Alerts - baoquankhu1.vn
Alcon Inc stock faces uncertainty as Lensar merger collapses, pivots to organic growth strategy - AD HOC NEWS
LENSAR Inc stock plunges as Alcon terminates merger over FTC antitrust block - AD HOC NEWS
LENSAR Inc stock faces prolonged uncertainty as Alcon merger awaits FTC approval amid regulatory del - AD HOC NEWS
LENSAR Inc stock faces uncertainty as Alcon merger awaits final regulatory approval amid pending FTC - ad-hoc-news.de
World Council of Optometry and Alcon Introduce Dry Eye Management Map - VisionMonday.com
Alcon Inc stock faces uncertainty as Lensar merger collapses, prompting strategic pivot to core eye - AD HOC NEWS
BTIG Reiterates 'Buy' Rating for Alcon (ALC) with $92 Price Targ - GuruFocus
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):